We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

88 hedge funds and large institutions have $471M invested in Abeona Therapeutics in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more call options, than puts

Call options by funds: $6.19M | Put options by funds: $3.17M

55% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 22

1% more capital invested

Capital invested by funds: $464M → $471M (+$6.24M)

0.27% more ownership

Funds ownership: 2.5% → 2.78% (+0.27%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 93 → 88 (-5)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

Holders
88
Holders Change
-5
Holders Change %
-5.38%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
34
Reduced
22
Closed
19
Calls
$6.19M
Puts
$3.17M
Net Calls
+$3.02M
Net Calls Change
+$4.87M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$24.1M
2
PA
Perceptive Advisors
New York
+$13.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.4M
4
Millennium Management
Millennium Management
New York
+$11.5M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$9.17M

Top Sellers

Rank Fund Capital Flow
1
CHP
Castle Hook Partners
New York
-$18.9M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$12.1M
3
Invesco
Invesco
Georgia
-$3.42M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$3.17M
5
EI
EAM Investors
California
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
26
Royce & Associates
New York
$2.04M – – –
Allianz Asset Management
27
Allianz Asset Management
Germany
$1.46M -$11.1K -30 -0.7%
KAM
28
Kavi Asset Management
New York
$1.25M -$1.89M -5,076 -59%
Citigroup
29
Citigroup
New York
$1.19M -$514K -1,383 -30%
TCIM
30
TIAA CREF Investment Management
New York
$959K +$8.17K +22 +0.8%
CT
31
Cambridge Trust
Massachusetts
$939K – – –
Charles Schwab
32
Charles Schwab
California
$902K +$96.6K +260 +12%
Hudson Bay Capital Management
33
Hudson Bay Capital Management
Connecticut
$864K +$895K +2,408 New
BGIM
34
Brandywine Global Investment Management
Pennsylvania
$846K -$322K -868 -27%
Goldman Sachs
35
Goldman Sachs
New York
$815K -$445K -1,198 -35%
TA
36
Teachers Advisors
New York
$738K – – –
Swiss National Bank
37
Swiss National Bank
Switzerland
$719K – – –
VEA
38
Virtus ETF Advisers
New York
$677K +$376K +1,012 +116%
Wells Fargo
39
Wells Fargo
California
$669K +$1.11K +3 +0.2%
AllianceBernstein
40
AllianceBernstein
Tennessee
$631K +$214K +576 +49%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$615K -$22.3K -60 -3%
AQR Capital Management
42
AQR Capital Management
Connecticut
$594K -$61.3K -165 -9%
AS
43
Altshuler Shaham
Israel
$531K +$550K +1,480 New
Alkeon Capital Management
44
Alkeon Capital Management
New York
$524K -$52K -140 -9%
CS
45
Credit Suisse
Switzerland
$499K +$21.9K +59 +4%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$466K +$265K +712 +121%
CIM
47
CIM Investment Management
Pennsylvania
$464K +$480K +1,292 New
AAP
48
Ardsley Advisory Partners
Connecticut
$428K -$149K -400 -25%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$405K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$402K +$19.7K +53 +5%
1
2
3 4 5

ABEO Hedge Fund Activity: Q1 2018 in Review

88 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2018, worth a combined $471M — up 1.3% from $464M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ABEO and 15 opened new positions — a net loss of 4 holders — while 22 trimmed existing stakes and 34 added.

The largest buyer was Citadel Advisors, adding an estimated $24.1M. The largest seller was Castle Hook Partners, exiting entirely with an estimated $18.9M sold.

  • 88 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2018, down from 93 in Q4 2017.
  • Funds reported $471M of Abeona Therapeutics stock for Q1 2018, up 1.3% quarter-over-quarter.
  • 15 funds opened new Abeona Therapeutics positions in Q1 2018 and 19 closed out, a net change of -4 holders.
  • The largest Abeona Therapeutics buyer in Q1 2018 was Citadel Advisors, an estimated $24.1M added.
  • The largest Abeona Therapeutics seller in Q1 2018 was Castle Hook Partners, an estimated $18.9M sold.

Based on aggregated 13F filings for Q1 2018.